Description

The 2018 multi-society guideline for management of blood cholesterol identifies patients at high and very high risk for future atherosclerotic cardiovascular (ASCVD) events.


Major ASCVD events:

(1) acute coronary syndrome within the past 12 months

(2) history of acute myocardial infarction (excluding item 1)

(3) history of ischemic stroke

(4) symptomatic peripheral arterial disease (PAD)

 

where:

Symptomatic PAD: one or more of amputation, previous revascularization or (claudication and ABI < 0.85)

 

High-risk conditions:

(1) age >= 65 years

(2) heterozygous familial hypercholesterolemia

(3) history of prior PCI or CABG outside of events listed above

(4) diabetes mellitus

(5) hypertension

(6) chronic kidney disease with eGFR 15-59 mL per min per 1.73 square meter

(7) current smoking

(8) history of congestive heart failure

(9) persistently elevated LDL-cholesterol (>= 100 mg/dL) despite maximally tolerated statin therapy and ezetimibe

 

A person is judged to be at very high risk if one of the following:

(1) >= 2 major ASCVD events

(2) 1 major ASCVD event AND "multiple" high risk conditions

 

A patient judged to be very high risk benefits from aggressive LDL-cholesterol lowering to below 70 mg/dL.


To read more or access our algorithms and calculators, please log in or register.